Ignite Creation Date:
2024-05-06 @ 7:35 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06065371
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-19
First Post:
2023-09-13
Brief Title:
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
Sponsor:
Henry Ford Health System
Organization:
Henry Ford Health System
Organization Data
Organization:
Henry Ford Health System
Class:
OTHER
Study ID:
HFH-23-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Henry Ford Health System
Lead Sponsor Class:
OTHER
Responsible Party:
Maria Diab
Responsible Party Title:
Assistant Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Henry Ford Health System
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Gilead Sciences | INDUSTRY |